High-throughput screening using a Drosophila model of Parkinson’s disease
Objective: To identify potential therapeutic compounds for Parkinson’s disease (PD) treatment by combining a phenotype-based high-throughput screening assay in PD model flies with a validation…Role of APOE ε4 status and Sex on Somatosensory Integration and Dual-Task Cost in Parkinson’s disease
Objective: To determine whether ε4 status relates to impaired somatosensory integration deficits in males more than females in people with Parkinson’s disease (PwPD). Background: Previous…Healthcare disparities in patients with Parkinson’s disease: A comprehensive literature review and call to action
Objective: To review the literature on healthcare disparities in Parkinson’s care in the United States and to initiate a community education program targeted at an…Diplopia and visual complaints in non-demented patients with Parkinson disease: a Japanese single center cross-sectional survey
Objective: To investigate the characterization of diplopia and visual complaints including minor forms of hallucinations (mHals) in non-demented patients with Parkinson disease (PD). Background: Double…Differences in resting state fMRI distinguish multiple system atrophy and Parkinson disease
Objective: To investigate whether functional connectivity of the hypothalamus can distinguish multiple system atrophy from Parkinson disease. Background: Multiple system atrophy parkinsonian subtype (MSA-P) and…Improving neuroprotective effects of resveratrol by brain targeting through chitosan glutamate nanoparticles in MPTP induced parkinsonism
Objective: The aim of the present study was to develop and evaluate the neuroprotective effects of resveratrol (RV) using chitosan glutamate nanoparticles (RV-CG-NPs) in a…Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features
Objective: We aim to study video-polysomnography (VPSG) and clinical features in patients with MSA. First, we investigate whether VPSG findings differ depending on the presence…Concentration of short chain fatty acids in the peripheral blood of patients with Parkinson disease
Objective: Based on the possible role of short chain fatty acids (SCFAs) on the permeability of the blood-brain barrier and its change in Parkinson disease…Frailty in Parkinson’s disease: A systematic review
Objective: The aim of this study was to examine the co-occurrence of frailty in people with PD; to describe the measures used to assess frailty…The effects of zonisamide on motor and non-motor symptoms in patients with Parkinson’s disease: a 3-month open-label study
Objective: To investigate the effect of zonisamide (ZNS) on motor and non-motor symptoms, such as depressive symptoms and sleep problems, in patients with Parkinson’s disease…
- « Previous Page
- 1
- …
- 168
- 169
- 170
- 171
- 172
- …
- 217
- Next Page »